Urticarial vasculitis - Vasculitis Urticarial
☆ Tamin'ny valin'ny Stiftung Warentest 2022 avy any Alemaina, ny fahafaham-pon'ny mpanjifa amin'ny ModelDerm dia ambany kely noho ny fifampidinihana telemedicine karama.
References
Urticarial vasculitis dia toe-javatra tsy fahita firy voamariky ny fizaran'ny hives maharitra na miverimberina. Na dia mety mitovy amin'ny tohotra mitaiza aza ny soritr'aretin'ny hodiny, dia miavaka izy ireo satria miraikitra mandritra ny 24 ora fara-fahakeliny ny tohotra ary mety miteraka pentina aorian'ny fahalavoana. Na dia matetika tsy fantatra aza ny antony, dia mety ho vokatry ny fanafody sasany, ny aretina, ny aretina autoimmune, ny aretin-drà, na ny homamiadana. Ny fanadihadiana sasany aza dia nampifandray izany tamin'ny gripa COVID-19 sy H1N1. Mety hisy fiantraikany amin'ny faritra hafa amin'ny vatana toy ny hozatra, voa, havokavoka, vavony ary maso izany. Na dia afaka manamarina ny aretina aza ny karazana fizahana sela sasany, dia tsy ilaina foana izany. Matetika ny fitsaboana dia manomboka amin'ny antibiotika, dapsone, colchicine, na hydroxychloroquine amin'ny tranga malemy kokoa. Ho an'ny tranga henjana kokoa, mety ilaina ny fanafody manafoana ny hery fiarovana toy ny methotrexate na corticosteroids. Vao haingana, ny fitsaboana biolojika (rituximab, omalizumab, interleukin-1 inhibitors) dia nampiseho fampanantenana ho an'ny tranga sarotra.
Urticarial vasculitis is a rare clinicopathologic entity that is characterized by chronic or recurrent episodes of urticarial lesions. Skin findings of this disease can be difficult to distinguish visually from those of chronic idiopathic urticaria but are unique in that individual lesions persist for ≥24 hours and can leave behind dusky hyperpigmentation. This disease is most often idiopathic but has been linked to certain drugs, infections, autoimmune connective disease, myelodysplastic disorders, and malignancies. More recently, some authors have reported associations between urticarial vasculitis and COVID-19, as well as influenza A/H1N1 infection. Urticarial vasculitis can extend systemically as well, most often affecting the musculoskeletal, renal, pulmonary, gastrointestinal, and ocular systems. Features of leukocytoclastic vasculitis seen on histopathologic examination are diagnostic of this disease, but not always seen. In practice, antibiotics, dapsone, colchicine, and hydroxychloroquine are popular first-line therapies, especially for mild cutaneous disease. In more severe cases, immunosuppressives, including methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine, as well as corticosteroids, may be necessary for control. More recently, select biologic therapies, including rituximab, omalizumab, and interleukin-1 inhibitors have shown promise for the treatment of recalcitrant or refractory cases.
Urticarial vasculitis is a rare clinicopathologic entity that is characterized by chronic or recurrent episodes of urticarial lesions. Skin findings of this disease can be difficult to distinguish visually from those of chronic idiopathic urticaria but are unique in that individual lesions persist for ≥24 hours and can leave behind dusky hyperpigmentation. This disease is most often idiopathic but has been linked to certain drugs, infections, autoimmune connective disease, myelodysplastic disorders, and malignancies. More recently, some authors have reported associations between urticarial vasculitis and COVID-19, as well as influenza A/H1N1 infection. Urticarial vasculitis can extend systemically as well, most often affecting the musculoskeletal, renal, pulmonary, gastrointestinal, and ocular systems. Features of leukocytoclastic vasculitis seen on histopathologic examination are diagnostic of this disease, but not always seen. In practice, antibiotics, dapsone, colchicine, and hydroxychloroquine are popular first-line therapies, especially for mild cutaneous disease. In more severe cases, immunosuppressives, including methotrexate, mycophenolate mofetil, azathioprine, and cyclosporine, as well as corticosteroids, may be necessary for control. More recently, select biologic therapies, including rituximab, omalizumab, and interleukin-1 inhibitors have shown promise for the treatment of recalcitrant or refractory cases.
Lehilahy iray 35 taona no niditra tao anatin’ny 15 andro, nahitana fivontosana mena midorehitra sy maharary teo amin’ny feny sy ny tongony, miaraka amin’ny fanaintainany. Narary izy nandritra ny herinandro talohan'ny nisehoan'ny maimaika. Nahita takela-bato mena maromaro miendrika peratra ny hodiny, teo amin'ny ilany roa amin'ny feny sy ny tongony. Nomena prednisolone am-bava izy (40mg/andro) mandritra ny herinandro miaraka amin'ny antihistamine tsy mampatory (fexofenadine) . Tao anatin'ny herinandro dia nanjavona tanteraka ny maimaika rehetra. Tsy nisy intsony ny maimaika nandritra ny 6 volana nanaraka tsy tapaka.
A 35-year-old man came in with a 15-day history of bright red, painful rashes on both thighs and legs, along with joint pain. He had a urinary tract infection for a week before the rash appeared. His skin showed several tender, ring-shaped, partially blanchable, red plaques on both sides of his thighs and legs. He was given oral prednisolone (40mg/day) for a week along with a non-drowsy antihistamine (fexofenadine). Within a week, all the rashes disappeared completely. There were no more rashes during the next 6 months of regular check-ups.
A 35-year-old man came in with a 15-day history of bright red, painful rashes on both thighs and legs, along with joint pain. He had a urinary tract infection for a week before the rash appeared. His skin showed several tender, ring-shaped, partially blanchable, red plaques on both sides of his thighs and legs. He was given oral prednisolone (40mg/day) for a week along with a non-drowsy antihistamine (fexofenadine). Within a week, all the rashes disappeared completely. There were no more rashes during the next 6 months of regular check-ups.
○ Fitsaboana - Fanafody OTC
Raha voan'ny tazo ianao (mitombo ny hafanan'ny vatana), dia manoro hevitra anao izahay hanatona mpitsabo faran'izay haingana.
Tokony hajanona ilay fanafody ahiana. (oh: antibiotika, fanafody manohitra ny inflammatoire tsy steroidal)
Antihistamine am-bava toy ny cetirizine na loratadine ho an'ny mangidihidy.
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]
Ny menaka steroid OTC dia mety tsy mahomby amin'ny hery ambany. Mila ampiharina mandritra ny herinandro mahery vao mahita fanatsarana.
#Hydrocortisone ointment